greeksoup/ stock research
Stock research / United States / RCUS / Planned sales

Arcus Biosciences, Inc. planned insider sales

In the twelve months since 11 October 2025 insiders at Arcus Biosciences, Inc. filed 26 Form 144 notices of planned sales, 746,559 shares worth $17.5 million at the time of filing, from 10 sellers. The latest, filed 21 August 2026: Alexander Azoy (officer), 2,827 shares worth $83,453, planned for around 21 August 2026 through Morgan Stanley Smith Barney LLC Executive Financial Services.

FiledSellerRelationshipSharesValuePlanned saleBrokerHow acquiredFiling
21 August 2026Alexander AzoyOfficer2,827$83,45321 August 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Stock OptionsForm 144
9 July 2026Juan JaenOfficer25,000$749,0009 July 2026Goldman Sachs & Co. LLCRestricted Stock UnitsForm 144
24 June 2026Juan JaenOfficer50,000$1.4 million24 June 2026Goldman Sachs & Co. LLCRestricted Stock UnitsForm 144
22 June 2026Juan JaenOfficer25,000$680,75022 June 2026Goldman Sachs & Co. LLCRestricted Stock UnitsForm 144
1 June 2026Alexander AzoyOfficer2,562$64,9211 June 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesEmployee Stock Purchase PlanForm 144
11 May 2026Robert C. Goeltz IIOfficer7,763$198,96611 May 2026Merrill LynchRestricted Stock UnitForm 144
6 May 2026Jennifer JarrettOfficer77,793$1.9 million6 May 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesStock Option ExerciseForm 144
23 April 2026Jennifer JarrettOfficer53,826$1.4 million23 April 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesStock Option ExerciseForm 144
8 April 2026Jennifer JarrettOfficer70,000$1.6 million8 April 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesStock Option ExerciseForm 144
5 January 2026Juan JaenOfficer31,823$692,7875 January 2026Goldman Sachs & Co. LLCAcquired from issuer in private transactionForm 144
31 December 2025Robert C. Goeltz IIOfficer6,552$153,18631 December 2025Merrill LynchRestricted Stock UnitForm 144
18 December 2025Alexander AzoyOfficer4,343$96,76218 December 2025Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
15 December 2025Alexander AzoyOfficer5,000$109,50016 December 2025E*TRADE FINANCIAL CORPORATIONVesting of restricted stock granted 1/23/2023; Vesting of restricted stock granted 1/23/2024; Vesting of restricted stock granted 1/23/2025; Vesting of restricted stock granted 3/8/2022Form 144
15 December 2025Richard MarkusOfficer10,000$219,00016 December 2025E*TRADE FINANCIAL CORPORATIONVesting of restricted stock granted 2/10/2025Form 144
15 December 2025Robert C. Goeltz, IIOfficer14,000$306,60016 December 2025E*TRADE FINANCIAL CORPORATIONVesting of restricted stock granted 1/23/2023; Vesting of restricted stock granted 1/23/2024; Vesting of restricted stock granted 1/23/2025; Vesting of restricted stock granted 3/8/2022Form 144
15 December 2025Carolyn TangOfficer15,000$328,50016 December 2025E*TRADE FINANCIAL CORPORATIONVesting of restricted stock granted 1/23/2023; Vesting of restricted stock granted 1/23/2024; Vesting of restricted stock granted 1/23/2025; Vesting of restricted stock granted 3/8/2022Form 144
15 December 2025Jennifer JarrettOfficer22,000$481,80016 December 2025E*TRADE FINANCIAL CORPORATIONVesting of restricted stock granted 1/23/2023; Vesting of restricted stock granted 1/23/2024; Vesting of restricted stock granted 1/23/2025; Vesting of restricted stock granted 3/8/2022Form 144
15 December 2025Juan JaenOfficer22,000$481,80016 December 2025E*TRADE FINANCIAL CORPORATIONVesting of restricted stock granted 1/23/2023; Vesting of restricted stock granted 1/23/2024; Vesting of restricted stock granted 1/23/2025; Vesting of restricted stock granted 3/8/2022Form 144
15 December 2025Terry Rosen, Ph.D.Officer, Director55,000$1.2 million16 December 2025E*TRADE FINANCIAL CORPORATIONVesting of restricted stock granted 1/23/2023; Vesting of restricted stock granted 1/23/2024; Vesting of restricted stock granted 1/23/2025; Vesting of restricted stock granted 3/8/2022Form 144
4 December 2025Juan JaenOfficer82,997$2.1 million4 December 2025Goldman Sachs & Co. LLCAcquired from issuer in private transactionForm 144
26 November 2025Alexander AzoyOfficer1,900$46,13226 November 2025Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Stock OptionsForm 144
26 November 2025Robert C. Goeltz IIOfficer5,000$125,00026 November 2025Merrill Lynch11/26/2025Form 144
17 November 2025Juan JaenOfficer50,000$999,50017 November 2025Goldman Sachs & Co. LLCAcquired from issuer in private transactionForm 144
30 October 2025Juan JaenOfficer1,173$23,68330 October 2025Goldman Sachs & Co. LLCAcquired from issuer in private transactionForm 144
28 October 2025Robert C. Goeltz IIOfficer5,000$100,00028 October 2025Merrill Lynch10/28/2025Form 144
28 October 2025Juan JaenOfficer100,000$2.0 million28 October 2025Goldman Sachs & Co. LLCAcquired from issuer in private transactionForm 144
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read moreValue is the filer's own aggregate market value. Whether the sale happened shows up later on Form 4, on the insiders page.

Source

Form 144 filings on EDGAR for Arcus Biosciences, Inc.: the company's filing index, each notice read from its own XML.

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install